New drug shows promise for rare stomach cancer in chinese patients
Disease control
Completed
This study tested the safety and effectiveness of avapritinib in 61 Chinese patients with a rare stomach cancer called GIST. Researchers monitored side effects and dose adjustments in real-world settings. The goal was to see how well the drug works outside of strict clinical tria…
Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC